About: Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women's cancers. Results of a prospective study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women's cancers. Results of a prospective study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 07 August 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2007 (uk) article scientifique publié en 2007 (fr) im August 2007 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 07 August 2007 (en) artículu científicu espublizáu n'agostu de 2007 (ast)
publication date	wds:Q80751855-2E2A7B8F-F110-4E46-821D-C1DB38C688E8
publication date	2007-08-07 00:00:00Z (xsd:dateTime)
exact match	wds:Q80751855-AED68CFA-AA83-4B8B-9FDA-DB42D4AF5415
exact match	https://scigraph.springernature.com/pub.10.1007/s00520-007-0318-8
cites work	wds:Q80751855-03FEEC5A-91E9-493D-93B0-4BDD780D6D5D wds:Q80751855-18C64925-B7BE-4521-8541-151478759B0B wds:Q80751855-1A483ABE-C4C6-4070-83D3-D9CCCE17B320 wds:Q80751855-1AA341F4-6B84-45F2-87B1-B9BC66D6A9A7 wds:Q80751855-40504530-6489-485D-920D-E3F787C8BAA2 wds:Q80751855-4C7B744F-B0A6-4DB2-947F-6071412B32E3 wds:Q80751855-4F396637-389F-40D2-AC0D-FA295D562F64 wds:Q80751855-5A1E2CFA-5D92-4776-A738-28C69DDA1D7E wds:Q80751855-5C1561EB-CDFB-4C30-BB8C-10EF70404E6F wds:Q80751855-5CBC75F3-9C9F-4DEE-B730-A070987C1CE4 wds:Q80751855-632C7ADA-0E67-4CEC-AF70-98EF8D4D8501 wds:Q80751855-6E65C042-473E-4A84-ACF4-59E2FD198A76 wds:Q80751855-74695012-B746-4E75-8638-4CBD102F45D3 wds:Q80751855-7585A5DA-0696-4C0F-8254-A41525F889F4 wds:Q80751855-75E08FC5-18A7-4042-96AF-D39DCEC071E5 wds:Q80751855-767C0BCC-6DBC-46D2-A6CC-78F0A347AAA5 wds:Q80751855-8468CD8D-AF12-455D-AB55-89AC39C6FAB3 wds:Q80751855-8B3ABD54-5352-4C33-8637-38FD9A2F1EE2 wds:Q80751855-94A17235-2774-444C-A10A-D05A3A7AC492 wds:Q80751855-9E2024AB-0567-4F19-9C5E-0F87B66E2388 wds:Q80751855-A78BACE3-4AA0-4DAD-91C2-9863DA85C00E wds:Q80751855-ABB14C45-9BAB-42CF-BB30-0CC5C63E9A6B wds:Q80751855-BB4C2EDE-57C9-4C35-A81A-094D4F7D8B77 wds:Q80751855-C0D9361E-1952-4692-BF1F-4814E8F5BDCE wds:Q80751855-E13E5780-101F-4304-9241-D87AB98AD4BC wds:Q80751855-E585B69B-1B33-4D89-A383-262E7E739C31 wds:Q80751855-E635967E-936D-4F11-8611-4D31430CE0AD wds:Q80751855-EE3C84B8-78E8-4CCE-B88E-A2DB1C619945 wds:Q80751855-F0D8BBC8-FB2D-4E21-8A85-E617D3AE1450 wds:Q80751855-F262A36A-C8DE-4680-9BB9-AE767C349AA9 wds:Q80751855-F579A0BA-AF3E-4439-BC5C-CA87407D1147 wds:Q80751855-FFA3FA61-8E82-4A71-A00F-727C2CE51A5A
cites work	Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. A phase II study evaluating the tolerability and efficacy of CAELYX (liposomal doxorubicin, Doxil) in the treatment of unresectable pancreatic carcinoma Liposomal doxorubicin in ovarian, peritoneal, and tubal carcinoma: a retrospective comparative study of single-agent dosages. Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia Mucocutaneous reactions to chemotherapy Breast cancer patients' expectations in respect of the physician-patient relationship and treatment management results of a survey of 617 patients. Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy Phase II study of liposomal doxorubicin in advanced gynecologic cancers The cutaneous histopathology of chemotherapeutic reactions Doxorubicin toxicity to the skin: possibility of protection with antioxidants enriched yeast Caelyx/Doxil for the treatment of metastatic ovarian and breast cancer Oral dexamethasone attenuates Doxil-induced palmar-plantar erythrodysesthesias in patients with recurrent gynecologic malignancies Onycholysis as a complication of systemic chemotherapy: report of five cases associated with prolonged weekly paclitaxel therapy and review of the literature Hand-foot syndrome induced by high-dose, short-term, continuous 5-fluorouracil infusion Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane High incidence of severe hand–foot syndrome during capecitabine–docetaxel combination chemotherapy Mucocutaneous complications of chemotherapy in 74 patients from Maharaj Nakorn Chiang Mai Hospital Fixed erythrodysaesthesia plaque due to intravenous injection of docetaxel The effect of regional cooling on toxicity associated with intravenous infusion of pegylated liposomal doxorubicin in recurrent ovarian carcinoma Onycholysis associated with weekly administration of paclitaxel Onycholysis in patients treated with docetaxel Cutaneous manifestations of Taxol therapy Hand-foot syndrome in patients treated with capecitabine-containing combination chemotherapy Palmar-plantar erythrodysestasia syndrome associated with 5-fluorouracil treatment Dermatologic toxicity of chemotherapy Chemotherapy-induced onycholysis [Hand-foot syndrome (palmar-plantar erythrodysesthesia]
author name string	wds:Q80751855-2664E7FA-CB8F-4938-A5D0-9B600C04150B wds:Q80751855-6D13CCD7-AC40-4AA2-BC0E-5070B3EFE468 wds:Q80751855-866EEE25-F9C3-44B4-BE01-289791A94CA4 wds:Q80751855-91E495EA-95BA-477F-AE06-31649CFA44F8
author name string	Jalid Sehouli Norbert Haas Christina Fotopoulou Werner Lichtenegger
rdfs:label	Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women's cancers. Results of a prospective study (en) Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women's cancers. Results of a prospective study (nl)
skos:prefLabel	Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women's cancers. Results of a prospective study (en) Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women's cancers. Results of a prospective study (nl)
name	Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women's cancers. Results of a prospective study (en) Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women's cancers. Results of a prospective study (nl)
author	wds:Q80751855-89F577E6-619A-4644-A051-504EBA143546
author	Mark Hackbarth
title	wds:Q80751855-40D03C96-8BF5-49EE-8737-6FA818CBB540
title	Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women's cancers. Results of a prospective study (en)
page(s)	wds:Q80751855-E61D2C0C-F94C-42AD-A3AA-E708847D175F
page(s)	267-273
instance of	wds:Q80751855-C817FA93-55B1-45D3-8A24-080F808E9D24
instance of	scholarly article
main subject	wds:Q80751855-67AB0E15-6946-4ACD-979C-2CD3769F35A1
main subject	chemotherapy
PubMed ID	wds:Q80751855-77C9945C-82C8-4245-8C94-EBB8D5F4AFB4

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software